These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37094430)

  • 1. Plasmacytoid dendritic cells stimulated with Lactococcus lactis strain Plasma produce soluble factors to suppress SARS-CoV-2 replication.
    Ishii H; Jounai K; Tsuji R; Ohshio K; Kaneda D; Okazaki M; Harada S; Fujiwara D; Matano T
    Biochem Biophys Res Commun; 2023 Jun; 662():26-30. PubMed ID: 37094430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmacytoid dendritic cell dysfunction caused by heat stress is improved by administration of
    Sugimura T; Jounai K; Ohshio K; Fujiwara D
    Biosci Biotechnol Biochem; 2019 Nov; 83(11):2140-2143. PubMed ID: 31318317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of anti-viral genes mediated by humoral factors upon stimulation with Lactococcus lactis strain plasma results in repression of dengue virus replication in vitro.
    Tsuji R; Yamamoto N; Yamada S; Fujii T; Yamamoto N; Kanauchi O
    Antiviral Res; 2018 Dec; 160():101-108. PubMed ID: 30393011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spherical lactic acid bacteria activate plasmacytoid dendritic cells immunomodulatory function via TLR9-dependent crosstalk with myeloid dendritic cells.
    Jounai K; Ikado K; Sugimura T; Ano Y; Braun J; Fujiwara D
    PLoS One; 2012; 7(4):e32588. PubMed ID: 22505996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmacytoid dendritic cells produce type I interferon and reduce viral replication in airway epithelial cells after SARS-CoV-2 infection.
    Cervantes-Barragan L; Vanderheiden A; Royer CJ; Davis-Gardner ME; Ralfs P; Chirkova T; Anderson LJ; Grakoui A; Suthar MS
    bioRxiv; 2021 May; ():. PubMed ID: 34013278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory effect of Lactococcus lactis JCM5805 on human plasmacytoid dendritic cells.
    Sugimura T; Jounai K; Ohshio K; Tanaka T; Suwa M; Fujiwara D
    Clin Immunol; 2013 Dec; 149(3):509-18. PubMed ID: 24239838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term administration of pDC stimulative lactic acid bacteria, Lactococcus lactis strain Plasma, prevents immune-senescence and decelerates individual senescence.
    Tsuji R; Komano Y; Ohshio K; Ishii N; Kanauchi O
    Exp Gerontol; 2018 Oct; 111():10-16. PubMed ID: 29964182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of
    Yamamoto K; Hosogaya N; Inoue T; Jounai K; Tsuji R; Fujiwara D; Yanagihara K; Izumikawa K; Mukae H
    BMJ Open; 2022 Sep; 12(9):e061172. PubMed ID: 36104128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2.
    Venet M; Ribeiro MS; Décembre E; Bellomo A; Joshi G; Nuovo C; Villard M; Cluet D; Perret M; Pescamona R; Paidassi H; Walzer T; Allatif O; Belot A; Trouillet-Assant S; Ricci EP; Dreux M
    Nat Commun; 2023 Feb; 14(1):694. PubMed ID: 36755036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term administration of pDC-Stimulative Lactococcus lactis strain decelerates senescence and prolongs the lifespan of mice.
    Sugimura T; Jounai K; Ohshio K; Suzuki H; Kirisako T; Sugihara Y; Fujiwara D
    Int Immunopharmacol; 2018 May; 58():166-172. PubMed ID: 29605632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmacytoid dendritic cells during COVID-19: Ally or adversary?
    Van der Sluis RM; Holm CK; Jakobsen MR
    Cell Rep; 2022 Jul; 40(4):111148. PubMed ID: 35858624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection.
    Severa M; Diotti RA; Etna MP; Rizzo F; Fiore S; Ricci D; Iannetta M; Sinigaglia A; Lodi A; Mancini N; Criscuolo E; Clementi M; Andreoni M; Balducci S; Barzon L; Stefanelli P; Clementi N; Coccia EM
    PLoS Pathog; 2021 Sep; 17(9):e1009878. PubMed ID: 34473805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus.
    Scheuplein VA; Seifried J; Malczyk AH; Miller L; Höcker L; Vergara-Alert J; Dolnik O; Zielecki F; Becker B; Spreitzer I; König R; Becker S; Waibler Z; Mühlebach MD
    J Virol; 2015 Apr; 89(7):3859-69. PubMed ID: 25609809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.
    Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P
    Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of Lactococcus lactis strain Plasma induces maturation of plasmacytoid dendritic cells and protection from rotavirus infection in suckling mice.
    Jounai K; Sugimura T; Morita Y; Ohshio K; Fujiwara D
    Int Immunopharmacol; 2018 Mar; 56():205-211. PubMed ID: 29414652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophil-mediated suppression and anti-IL-5 enhancement of plasmacytoid dendritic cell interferon responses in asthma.
    Dill-McFarland KA; Schwartz JT; Zhao H; Shao B; Fulkerson PC; Altman MC; Gill MA
    J Allergy Clin Immunol; 2022 Sep; 150(3):666-675. PubMed ID: 35413355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19.
    Laurent P; Yang C; Rendeiro AF; Nilsson-Payant BE; Carrau L; Chandar V; Bram Y; tenOever BR; Elemento O; Ivashkiv LB; Schwartz RE; Barrat FJ
    Sci Immunol; 2022 Sep; 7(75):eadd4906. PubMed ID: 36083891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection.
    van der Sluis RM; Cham LB; Gris-Oliver A; Gammelgaard KR; Pedersen JG; Idorn M; Ahmadov U; Hernandez SS; Cémalovic E; Godsk SH; Thyrsted J; Gunst JD; Nielsen SD; Jørgensen JJ; Bjerg TW; Laustsen A; Reinert LS; Olagnier D; Bak RO; Kjolby M; Holm CK; Tolstrup M; Paludan SR; Kristensen LS; Søgaard OS; Jakobsen MR
    EMBO J; 2022 May; 41(10):e109622. PubMed ID: 35178710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the Plasmacytoid Dendritic Cell Response to Transmitted/Founder and Nontransmitted Variants of HIV-1.
    Schwartz JA; Zhang H; Ende Z; Deymier MJ; Lee T; Singer J; Mazzulli T; Hunter E; Ostrowski MA
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGB1 Is Involved in IFN-α Production and TRAIL Expression by HIV-1-Exposed Plasmacytoid Dendritic Cells: Impact of the Crosstalk with NK Cells.
    Saïdi H; Bras M; Formaglio P; Melki MT; Charbit B; Herbeuval JP; Gougeon ML
    PLoS Pathog; 2016 Feb; 12(2):e1005407. PubMed ID: 26871575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.